Corporate finance

Optimal solutions for your individual financial requirements.

SilverSky LifeSciences is a leading consultancy with the dedicated aim of providing its clients with custom-tailored solutions for their individual financial requirements. Our typical clientele are primarily owner-managed, small to mid-sized companies within the IVD and lifescience industry, medical devices, biotech and drug-screening companies. Through the extensive experience of our consultants in operation management or as founders of companies within these fields, we know, understand and can satisfy your company’s specific demands. SilverSky LifeSciences offers you, by virtue of the breadth and depth of its consultants’ expertise, the best possible chance of successfully completing their desired transaction. Hereby, we do not apply one-fit-all processes but develop individual solutions.

We are fully committed to working with you to find the optimal solution for your financial needs and to professionally accompany you in the implementation of your individual entrepreneurial project – competent, dedicated and solution-oriented.

Together, we develop a financing strategy that suits you and is tailored to your individual requirements and expectations.
Within the Corporate Finance world we have specialied on

  • Finding acquisition partners and supporting trade sales
  • Developing and implementing ‘Buy & Build’ strategies
  • Securing growth-capital
  • Enabling risk-financing
  • Negotiating licensing deals

Together, we prepare an individual and thorough deal plan, which will form a key part of your value creation strategy in order to ensure your competitive edge. Hence, we will support you through all phases of our joint project:

  • Strategic planning and goal setting
  • Preparation, structuring and initiation of business transactions
  • Analysis and evaluation of target companies
  • Identification and communication with target companies or investors, including arrangement of necessary documentation
  • Preparation, implementation and supervision of the due diligence process
  • Facilitation of contract negotiations through to conclusion
  • In case of mergers, support integration if needed.

SilverSky LifeSciences prides itself as an impartial partner throughout its involvement in your corporate finance / M&A dealings.
Our specific advantages compared to large corporate finance firms and small boutiques are:

  • Senior partner involvement
  • Deep industry knowledge
  • Commitment not only to larger but also to small transactions as well
  • Personal network of buyers / investors and industry partners
  • Devoted to advisory function
  • Strong entrepreneur perspective
  • Experience in structured deals and cross-border transactions

We believe that we offer a unique combination of expertise and network of former McKinsey consultants & technology and life science industry expertise with senior partner commitment of a boutique corporate fiance advisory.

We strongly believe our deal experience. And our industry knowledge. And the need to understand your technologies and products in detail to find the perfect partner match?. To live up to our own standard we have specialized on three industry sectors:

• Diagnostics
• Medtech
• Biotech / Drug-screening

For all of our corporate financing and M&A services in these industries, we bring added value through our own working experience and decade long personal network to investors and partners to accompany you with competence, commitment and focus to reach your goal.

Besides our connections with European, US and Asian Business Angels, Family Offices and Venture Capital providers, we have an extensive network to strategic partners and investors from the MedTech, Diagnostics and Biotech industry as well as Non- governmental organization. Importantly, through our own work in building companies in these areas, handling of successful financing projects and by employing consultants who are fluent in German, English and Chinese, we have a unique, global access to foreign investors and business partners for securing capital and negotiating partnerships.

Particular Chinese enterprises have recently emerged as strong investors. In the future, business and finance transactions between Asian in particular Chinese and European companies are expected to escalate. This is especially relevant for start-up and young organizations, as such dealings are usually long-term and provide a unique advantage for a successful opening into one of the World’s most important markets. Against this background, cross-border relationships with China, particularly within the Life Science Sector, are increasingly important. However, successful partnerships require professional handling, whereby internationally experienced intermediaries and advisors are essential. For this reason we have launched a dedicated SilverSky China Practice that support our deal teams with multilingual and intercultureal skills.

To better serve our clients SilverSky founded a dedicated China Practice in 2017 (link to entsprechender Sektion im Business Building) supporting companies that seek financing from China or want to build partnerships with Chinese entities. Our China Practice supports our clients in finding the appropriate partner and if needed enables relocating part or all of your activities to China. At the same time, growing interest has been shown by Chinese investors to take equity positions in promising technologies outside their country. Here, again, the SilverSky China Practice adresses Chinese companies’ demands by serving as a viable platform to facilitate equity investments by Chinese entities and individuals. Click here or learn more about the SilverSky China Practice.

Mirko Stange CEO of the Silversky group

Mirko Stange

Central contact for corporate finance /
M&A at Silversky LifeSciences

contact

Silversky Unternehmensberatung GmbH

Brunnenstrasse 23 40223 Düsseldorf
Germany

E-Mail: info@silversky-lifesciences.com

Legal disclosure | Datenschutz

WRITE US AN EMAIL